Patents by Inventor Frederic Bal

Frederic Bal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors
    Publication number: 20140051839
    Abstract: A process for reduction and/or removal of FXI and FXIa from a source solution containing said coagulation factors and as main components immunoglobulins comprising the following steps: a) contacting the FXI and/or FXIa containing solution with an affinity chromatographic gel wherein heparin or heparan is linked to the matrix material; b) allowing adsorption of FXI and/or FXIa and c) separation of the liquid deprived of FXI and/or FXIa from the adsorption media.
    Type: Application
    Filed: November 16, 2011
    Publication date: February 20, 2014
    Applicant: Octapharma AG
    Inventors: Petra Schultz, Gerhard Gruber, Frederic Bal, Frank Marks, Stefan Winge
  • Method for the inactivation of non-lipid-coated viruses
    Patent number: 6528246
    Abstract: A method for the inactivation of viruses, in particular those having no lipid coats, in protein-containing compositions from blood, blood plasma or similar natural sources by treating said source, simultaneously or succesively, with an effective amount of dialkyl or trialkyl phosphates and optionally surfactants at an elevated temperature in the range of from 55° C. to 67° C. for five hours to 30 hours.
    Type: Grant
    Filed: September 28, 1995
    Date of Patent: March 4, 2003
    Assignee: Octapharma AG
    Inventors: Monika Stadler, Horst Schwinn, Djuro Josic, Werner Gehringer, Frederic Bal
  • A METHOD FOR THE INACTIVATION OF NON-LIPID-COATED VIRUSES
    Publication number: 20020068355
    Abstract: A method for the inactivation of viruses, in particular those having no lipid coats, in protein-containing compositions from blood, blood plasma or similar natural sources by treating said source, simultaneously or succesively, with an effective amount of dialkyl or trialkyl phosphates and optionally surfactants at an elevated temperature in the range of from 55° C. to 67° C. for five hours to 30 hours.
    Type: Application
    Filed: September 28, 1995
    Publication date: June 6, 2002
    Inventors: MONIKA STADLER, HORST SCHWINN, DJURO JOSIC, WERNER GEHRINGER, FREDERIC BAL
  • Virus-inactivated 2-component fibrin glue
    Patent number: 6019993
    Abstract: A two-component fibrin glue for human application includes a) a component A containing i) a virus-inactivated and concentrated cryoprecipitate that contains fibrinogen, and ii) tranexamic acid or a pharmaceutically acceptable salt, thereof; and b) component B containing a proteolytic enzyme that, upon combination with component A, cleaves, specifically, fibrinogen present in the cryoprecipitate of component A, thereby, effecting a fibrin polymer.
    Type: Grant
    Filed: November 30, 1995
    Date of Patent: February 1, 2000
    Assignee: Omrix Biopharmaceuticals S.A.
    Inventor: Frederic Bal